Entrepreneur Resource Headquarters

International Expansion

Morgan Lewis supplies a wealth of information for technology and life sciences companies looking to grow overseas. Materials of particular interest to each niche are identified.

Bringing a Drug to Market in the European Union: Regulatory, Corporate, and Taxation Issues (Chapter 33), Emerging Life Sciences Companies Deskbook – Spring 2008 (Morgan Lewis)
This chapter offers insight into the EU’s regulatory regime for companies wishing to conduct clinical trials or obtain authorizations for medicinal products and medical devices in the EU. It also discusses tax, commercial, and corporate considerations that will assist pharmaceutical companies to plan appropriate and optimal strategies for entry into or expansion within the EU.
View the chapter >>

LifeSci

Doing Business in China (Chapter 34), Emerging Life Sciences Companies Deskbook – Spring 2008 (Morgan Lewis)
This chapter provides a brief overview of structuring, corporate, commercial, IP, and tax issues that foreign investors should consider before doing business in China.
View the chapter >>

LifeSci

Expanding to the United States: Issues for a Biotech Company to Consider in Preparing for a U.S. Market Entry (Chapter 36), Emerging Life Sciences Companies Deskbook – Spring 2008 (Morgan Lewis)
When a foreign biotech company decides to expand its operation beyond its borders and into the United States, such a decision brings with it not only a number of opportunities but also a number of challenges (e.g., where to locate, from where to hire employees, how to navigate the different regulatory regimes). This outline sets forth some of the issues and considerations that need to be made by a foreign company when preparing for market entry into the United States.
View the chapter >>

LifeSci

Regulation of Pharmaceutical Products and Medical Devices in Japan (Chapter 35), Emerging Life Sciences Companies Deskbook – Spring 2008 (Morgan Lewis)
This chapter highlights the major points to bear in mind when manufacturing, importing, marketing, or engaging in other businesses involving pharmaceutical products and medical devices in Japan.
View the chapter >>

LifeS